...
drrx-img

Durect Corporation, Common Stock

DRRX

NAQ

$0.771

-$0.02

(-2.52%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$24.66M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
44.93K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.13
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.48 L
$1.88 H
$0.771

About Durect Corporation, Common Stock

DURECT Corporation, a biopharmaceutical company, develops medicines based on its epigenetic regulator program. The company's lead product larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. It also offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine over three days in adults; and Methydur to treat attention deficit hyperactivity disorder. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in other countries. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; and Innocoll Pharmaceuticals Limited. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameDRRXSectorS&P500
1-Week Return-6.58%-1.8%-0.77%
1-Month Return-40.23%-3.48%0.71%
3-Month Return-50.89%-7.2%8.81%
6-Month Return-46.83%-1.54%12.32%
1-Year Return27.42%8.39%30.57%
3-Year Return-92.13%6.07%29.21%
5-Year Return-95.96%44.07%91.95%
10-Year Return-90.82%106.3%196.04%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue29.56M30.11M13.98M19.28M8.55M[{"date":"2019-12-31","value":98.18,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":46.42,"profit":true},{"date":"2022-12-31","value":64.04,"profit":true},{"date":"2023-12-31","value":28.39,"profit":true}]
Cost of Revenue4.14M1.41M1.96M1.59M1.72M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":33.94,"profit":true},{"date":"2021-12-31","value":47.19,"profit":true},{"date":"2022-12-31","value":38.33,"profit":true},{"date":"2023-12-31","value":41.44,"profit":true}]
Gross Profit25.42M28.70M12.02M17.70M6.83M[{"date":"2019-12-31","value":88.56,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":41.88,"profit":true},{"date":"2022-12-31","value":61.64,"profit":true},{"date":"2023-12-31","value":23.8,"profit":true}]
Gross Margin85.99%95.33%86.01%91.76%79.91%[{"date":"2019-12-31","value":90.2,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":90.23,"profit":true},{"date":"2022-12-31","value":96.26,"profit":true},{"date":"2023-12-31","value":83.83,"profit":true}]
Operating Expenses44.57M41.32M46.30M52.78M43.72M[{"date":"2019-12-31","value":84.45,"profit":true},{"date":"2020-12-31","value":78.29,"profit":true},{"date":"2021-12-31","value":87.72,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":82.83,"profit":true}]
Operating Income(19.15M)(12.62M)(34.27M)(35.08M)(36.88M)[{"date":"2019-12-31","value":-1915100000,"profit":false},{"date":"2020-12-31","value":-1261500000,"profit":false},{"date":"2021-12-31","value":-3427300000,"profit":false},{"date":"2022-12-31","value":-3508200000,"profit":false},{"date":"2023-12-31","value":-3688400000,"profit":false}]
Total Non-Operating Income/Expense(2.85M)(3.44M)(3.98M)(502.00K)9.79M[{"date":"2019-12-31","value":-29.14,"profit":false},{"date":"2020-12-31","value":-35.12,"profit":false},{"date":"2021-12-31","value":-40.67,"profit":false},{"date":"2022-12-31","value":-5.13,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(20.58M)(14.34M)(36.27M)(35.33M)(27.62M)[{"date":"2019-12-31","value":-2057800000,"profit":false},{"date":"2020-12-31","value":-1433500000,"profit":false},{"date":"2021-12-31","value":-3626500000,"profit":false},{"date":"2022-12-31","value":-3533300000,"profit":false},{"date":"2023-12-31","value":-2762400000,"profit":false}]
Income Taxes2.21M(11.81M)1.86M251.00K(19.89K)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-534.52,"profit":false},{"date":"2021-12-31","value":84.16,"profit":true},{"date":"2022-12-31","value":11.36,"profit":true},{"date":"2023-12-31","value":-0.9,"profit":false}]
Income After Taxes(22.79M)(2.52M)(38.13M)(35.58M)(27.60M)[{"date":"2019-12-31","value":-2278800000,"profit":false},{"date":"2020-12-31","value":-252200000,"profit":false},{"date":"2021-12-31","value":-3812500000,"profit":false},{"date":"2022-12-31","value":-3558400000,"profit":false},{"date":"2023-12-31","value":-2760410500,"profit":false}]
Income From Continuous Operations(20.58M)(14.34M)(36.27M)(35.33M)(36.65M)[{"date":"2019-12-31","value":-2057800000,"profit":false},{"date":"2020-12-31","value":-1433500000,"profit":false},{"date":"2021-12-31","value":-3626500000,"profit":false},{"date":"2022-12-31","value":-3533300000,"profit":false},{"date":"2023-12-31","value":-3665200000,"profit":false}]
Income From Discontinued Operations13.75M13.75M---[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(22.79M)(2.52M)(38.13M)(35.58M)(27.62M)[{"date":"2019-12-31","value":-2278800000,"profit":false},{"date":"2020-12-31","value":-252200000,"profit":false},{"date":"2021-12-31","value":-3812500000,"profit":false},{"date":"2022-12-31","value":-3558400000,"profit":false},{"date":"2023-12-31","value":-2762400000,"profit":false}]
EPS (Diluted)(1.10)(0.70)(1.60)(1.56)(1.13)[{"date":"2019-12-31","value":-110,"profit":false},{"date":"2020-12-31","value":-70,"profit":false},{"date":"2021-12-31","value":-160,"profit":false},{"date":"2022-12-31","value":-156,"profit":false},{"date":"2023-12-31","value":-113,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

DRRX
Cash Ratio 0.51
Current Ratio 0.71
Quick Ratio 0.60

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

DRRX
ROA (LTM) -39.70%
ROE (LTM) -299.88%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

DRRX
Debt Ratio Lower is generally better. Negative is bad. 0.95
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.05

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

DRRX
Trailing PE NM
Forward PE NM
P/S (TTM) 2.85
P/B 20.26
Price/FCF NM
EV/R 3.26
EV/Ebitda NM
PEG NM

FAQs

What is Durect Corporation share price today?

Durect Corporation (DRRX) share price today is $0.771

Can Indians buy Durect Corporation shares?

Yes, Indians can buy shares of Durect Corporation (DRRX) on Vested. To buy Durect Corporation from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in DRRX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Durect Corporation be purchased?

Yes, you can purchase fractional shares of Durect Corporation (DRRX) via the Vested app. You can start investing in Durect Corporation (DRRX) with a minimum investment of $1.

How to invest in Durect Corporation shares from India?

You can invest in shares of Durect Corporation (DRRX) via Vested in three simple steps:

  • Click on Sign Up or Invest in DRRX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Durect Corporation shares
What is Durect Corporation 52-week high and low stock price?

The 52-week high price of Durect Corporation (DRRX) is $1.88. The 52-week low price of Durect Corporation (DRRX) is $0.48.

What is Durect Corporation price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Durect Corporation (DRRX) is

What is Durect Corporation price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Durect Corporation (DRRX) is 20.26

What is Durect Corporation dividend yield?

The dividend yield of Durect Corporation (DRRX) is 0.00%

What is the Market Cap of Durect Corporation?

The market capitalization of Durect Corporation (DRRX) is $24.66M

What is Durect Corporation’s stock symbol?

The stock symbol (or ticker) of Durect Corporation is DRRX

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top